Role of blood-based factors in development and progression of heart failure (HF) is poorly characterized. Blood contains factors released during pathophysiological states that may impact cellular function and provide mechanistic insights to HF management. We tested effects of blood from two distinct HF models on cardiac metabolism and identified possible cellular targets of the effects. Blood plasma was obtained from daunorubicin- and myocardial infarction-induced HF rabbits (Dauno-HF and MI-HF) and their controls (Dauno-Control and MI-Control). Effects of plasma on bioenergetics of myocardial tissue from healthy mice and cellular cardiac components were assessed using high-resolution respirometry and Seahorse flux analyzer. Since endotheli...
Heart failure (HF) with preserved left ventricular ejection fraction (HFpEF) is becoming the predomi...
Deterioration of ventricular fibrillation (VF) into asystole or severe bradycardia (electrical failu...
AIMS:To determine the metabolic adaptations to compensated heart failure using a reproducible model ...
Ea.hy926 endothelial cells were grown and serum-starved for 2 h, followed by exposure to the rabbit ...
Background/Objectives: In heart failure pro-inflammatory cytokines contribute to cardiomyocytes loss...
The emerging novel heart failure (HF) biomarkers have been shown to provide additional value for pro...
Heart failure (HF) is a leading cause of hospitalization in patients aged more than 65 years and is ...
Heart failure (HF) is a condition in which the working heart is unable to meet the blood flow demand...
The emerging novel heart failure (HF) biomarkers have been shown to provide additional value for pro...
Heart failure with preserved ejection fraction (HFpEF) has been recognized as the greatest single un...
BACKGROUND AND PURPOSE: The formation of reactive oxygen species (ROS) is increased in heart failure...
Cardiovascular diseases (CVD) are the leading cause of death worldwide. CVD comprise a range of dise...
OBJECTIVES: The present study investigated whether systemic, low-grade inflammation of metabolic ris...
The shift in substrate preference away from fatty acid oxidation (FAO) towards increased glucose uti...
Heart failure (HF) with preserved left ventricular ejection fraction (HFpEF) is becoming the predomi...
Heart failure (HF) with preserved left ventricular ejection fraction (HFpEF) is becoming the predomi...
Deterioration of ventricular fibrillation (VF) into asystole or severe bradycardia (electrical failu...
AIMS:To determine the metabolic adaptations to compensated heart failure using a reproducible model ...
Ea.hy926 endothelial cells were grown and serum-starved for 2 h, followed by exposure to the rabbit ...
Background/Objectives: In heart failure pro-inflammatory cytokines contribute to cardiomyocytes loss...
The emerging novel heart failure (HF) biomarkers have been shown to provide additional value for pro...
Heart failure (HF) is a leading cause of hospitalization in patients aged more than 65 years and is ...
Heart failure (HF) is a condition in which the working heart is unable to meet the blood flow demand...
The emerging novel heart failure (HF) biomarkers have been shown to provide additional value for pro...
Heart failure with preserved ejection fraction (HFpEF) has been recognized as the greatest single un...
BACKGROUND AND PURPOSE: The formation of reactive oxygen species (ROS) is increased in heart failure...
Cardiovascular diseases (CVD) are the leading cause of death worldwide. CVD comprise a range of dise...
OBJECTIVES: The present study investigated whether systemic, low-grade inflammation of metabolic ris...
The shift in substrate preference away from fatty acid oxidation (FAO) towards increased glucose uti...
Heart failure (HF) with preserved left ventricular ejection fraction (HFpEF) is becoming the predomi...
Heart failure (HF) with preserved left ventricular ejection fraction (HFpEF) is becoming the predomi...
Deterioration of ventricular fibrillation (VF) into asystole or severe bradycardia (electrical failu...
AIMS:To determine the metabolic adaptations to compensated heart failure using a reproducible model ...